Bacitracin-Neomycin-Polymyxin

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1540.0%

Death Rate

Active Ingredients

Bacitracin-Neomycin-Polymyxin

Administration Routes

OphthalmicIntraocularUnknownTopical

Species Affected

Dog 11

Cat 2

Most Affected Breeds

Retriever - Labrador 4

Domestic Shorthair 2

Chihuahua 1

Terrier - Yorkshire 1

Terrier - Boston 1

Pinscher - Miniature 1

Terrier - West Highland White 1

Shih Tzu 1

Poodle (unspecified) 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 3

Elevated alanine aminotransferase (ALT) 3

Elevated serum alkaline phosphatase (SAP) 3

Vomiting 3

Corneal ulcer 3

Swelling around eye 2

Cough 2

Circling - neurological disorder (see also 'Behavioural disorders') 2

Elevated liver enzymes 2

Eyelid oedema 1

Eye disorder NOS (for photophobia see 'neurological') 1

Conjunctival oedema 1

Outcome Breakdown

Ongoing

7 (53.8%)

Recovered/Normal

3 (23.1%)

Died

2 (15.4%)

Outcome Unknown

1 (7.7%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.